Travere Therapeutics Inc

+0.71 (+2.89%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.62B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$54.45 Million
Adjusted EPS-$0.96
See more estimates
10-Day MA$25.38
50-Day MA$26.15
200-Day MA$26.13
See more pivots

Travere Therapeutics Inc Stock, NASDAQ:TVTX

3611 Valley Centre Drive, Suite 300, San Diego, California 92130
United States of America
Phone: +1.888.969.7879
Number of Employees: 310


Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.